BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22220274)

  • 1. Glutamate Transporter GLT-1 Upregulation Attenuates Visceral Nociception and Hyperalgesia via Spinal Mechanisms Not Related to Anti-Inflammatory or Probiotic Effects.
    Lin Y; Roman K; Foust KD; Kaspar BK; Bailey MT; Stephens RL
    Pain Res Treat; 2011; 2011():507029. PubMed ID: 22220274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact and mechanism of glutamate transporter 1-mediated visceral nociception and hyperalgesia following exposure to post-traumatic stress disorder-like stress in spinal cord of rats].
    Chen Q; Ji L; He Y; Ran Y; Lin L; Li L; Wang J; Wang Z; Yang M
    Zhonghua Nei Ke Za Zhi; 2014 Jun; 53(6):477-81. PubMed ID: 25146518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLT-1 overexpression attenuates bladder nociception and local/cross-organ sensitization of bladder nociception.
    Yang M; Roman K; Chen DF; Wang ZG; Lin Y; Stephens RL
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1353-9. PubMed ID: 21429971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Visceral Antinociceptive Effect of Glial Glutamate Transporter GLT-1 Upregulation by Ceftriaxone.
    Roman K; Yang M; Stephens RL
    ISRN Pain; 2013; 2013():726891. PubMed ID: 27335870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders.
    Ramos KM; Lewis MT; Morgan KN; Crysdale NY; Kroll JL; Taylor FR; Harrison JA; Sloane EM; Maier SF; Watkins LR
    Neuroscience; 2010 Sep; 169(4):1888-900. PubMed ID: 20547213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats.
    Hu Y; Li W; Lu L; Cai J; Xian X; Zhang M; Li Q; Li L
    Pain; 2010 Feb; 148(2):284-301. PubMed ID: 20022427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased glial glutamate transporter EAAT2 expression reduces visceral nociceptive response in mice.
    Lin Y; Tian G; Roman K; Handy C; Travers JB; Lin CL; Stephens RL
    Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G129-34. PubMed ID: 19023027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats.
    Maeda S; Kawamoto A; Yatani Y; Shirakawa H; Nakagawa T; Kaneko S
    Mol Pain; 2008 Dec; 4():65. PubMed ID: 19108711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glial glutamate transporter activator in formalin-induced pain behaviour in mice.
    Alotaibi G; Rahman S
    Eur J Pain; 2019 Apr; 23(4):765-783. PubMed ID: 30427564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tetanically sciatic stimulation-induced LTP of spinal neurons and Fos expression by disrupting glutamate transporter GLT-1.
    Wang ZY; Zhang YQ; Zhao ZQ
    Neuropharmacology; 2006 Sep; 51(4):764-72. PubMed ID: 16815482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate transporter activators as anti-nociceptive agents.
    Stephens RL
    Eurasian J Med; 2011 Dec; 43(3):182-5. PubMed ID: 25610189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation.
    Chu K; Lee ST; Sinn DI; Ko SY; Kim EH; Kim JM; Kim SJ; Park DK; Jung KH; Song EC; Lee SK; Kim M; Roh JK
    Stroke; 2007 Jan; 38(1):177-82. PubMed ID: 17122424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroacupuncture Alleviated Referral Hindpaw Hyperalgesia via Suppressing Spinal Long-Term Potentiation (LTP) in TNBS-Induced Colitis Rats.
    Lv PR; Su YS; He W; Wang XY; Shi H; Zhang XN; Zhu B; Kan Y; Chen LZ; Wu QF; Yu SG; Jing XH
    Neural Plast; 2019; 2019():2098083. PubMed ID: 30984253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of GLT-1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability.
    Nicholson KJ; Gilliland TM; Winkelstein BA
    J Neurosci Res; 2014 Jan; 92(1):116-29. PubMed ID: 24123246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of spinal nociceptive processing through the glutamate transporter GLT-1.
    Niederberger E; Schmidtko A; Rothstein JD; Geisslinger G; Tegeder I
    Neuroscience; 2003; 116(1):81-7. PubMed ID: 12535941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model.
    Inui T; Alessandri B; Heimann A; Nishimura F; Frauenknecht K; Sommer C; Kempski O
    Neuroscience; 2013 Jul; 242():1-10. PubMed ID: 23523747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-146a-5p attenuates visceral hypersensitivity through targeting chemokine CCL8 in the spinal cord in a mouse model of colitis.
    Lu Y; Cao DL; Zhao LX; Han Y; Zhang YL
    Brain Res Bull; 2018 May; 139():235-242. PubMed ID: 29550454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice.
    Morioka N; Zhang FF; Nakamura Y; Kitamura T; Hisaoka-Nakashima K; Nakata Y
    Brain Behav Immun; 2015 Oct; 49():293-310. PubMed ID: 26116449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riluzole normalizes early-life stress-induced visceral hypersensitivity in rats: role of spinal glutamate reuptake mechanisms.
    Gosselin RD; O'Connor RM; Tramullas M; Julio-Pieper M; Dinan TG; Cryan JF
    Gastroenterology; 2010 Jun; 138(7):2418-25. PubMed ID: 20226190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression.
    LaCrosse AL; O'Donovan SM; Sepulveda-Orengo MT; McCullumsmith RE; Reissner KJ; Schwendt M; Knackstedt LA
    J Neurosci; 2017 Jun; 37(24):5809-5821. PubMed ID: 28495973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.